- Amneal Pharmaceuticals ( NYSE: AMRX ) is scheduled to announce Q4 earnings results on Thursday, March 2nd, before market open.
- The consensus EPS Estimate is $0.21 (+16.7% Y/Y) and the consensus Revenue Estimate is $579.93M (+8.0% Y/Y).
- Over the last 2 years, AMRX has beaten EPS estimates 50% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 2 downward. Revenue estimates have seen 1 upward revision and 0 downward.
For further details see:
Amneal Pharmaceuticals Q4 2022 Earnings Preview